Indian Shares Open Lower On Inflation Worries

India, Sept. 1 -- Indian shares were subdued in early trade on Tuesday as surging oil prices fueled worries over inflation and raised the likelihood of tighter monetary policy, with traders now pricin... Read More

Happiest Minds To Merge With ITC Infotech, Target $1 Bln Revenue By FY28

India, Sept. 1 -- Happiest Minds Technologies Ltd. (HAPPSTMNDS.NS), the Bengaluru-based digital engineering company, announced on Tuesday that it has signed definitive agreements to merge with ITC Inf... Read More

Dave & Tems' 'Raindance' Leads Billboard's Mainstream R&B/Hip-Hop Airplay Chart

India, Sept. 1 -- Dave and Tems' collaboration "Raindance" tops Billboard's Mainstream R&B/Hip-Hop Airplay chart dated August 29, advancing from the previous week's No. 4 position. "Raindance" danced... Read More

Polaryx Appoints Charlton As CMO; PLX-200 Set For Phase 2 In Q4 '26

India, Sept. 1 -- Polaryx Therapeutics Inc. (PLYX), a clinical-stage biotechnology company, on Tuesday reported the appointment of Dr. Will Charlton as Chief Medical Officer (CMO), effective from Sept... Read More

LG Energy Solution Secures 10-year U.S. Lithium Supply Deal With Smackover Lithium

India, Aug. 31 -- LG Energy Solution, Ltd. (373220.KS) announced on Monday that it has signed a binding offtake agreement with Smackover Lithium to source 8,000 metric tonnes of battery-quality lithiu... Read More

Lexicon's Sotagliflozin Shows Consistent Benefit For Heart Failure In Phase 3 Post-Hoc Data

India, Aug. 31 -- Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company, on Monday reported new post-hoc results from the Phase 3 SOLOIST-WHF analysis. Sotagliflozin is an oral dual sodiu... Read More

RedHill Biopharma Stock Surges 64% Over Deal To Divest Talicia Business

India, Aug. 31 -- Shares of RedHill Biopharma Ltd. (RDHL) are surging about 64 percent on Monday morning after the company announced its decision to divest its Talicia business to a subsidiary of Apot... Read More

Palvella Completes Rolling NDA For QTORIN Rapamycin In Microcystic Lymphatic Malformatios

India, Aug. 31 -- Palvella Therapeutics, Inc. (PVLA) announced that it has completed the rolling submission of its NDA to the U.S. FDA for QTORIN 3.9% rapamycin anhydrous gel. The therapy is being de... Read More

How To Read A Biotech Clinical Trial Result: P-values, Endpoints, And Investor Implications

India, Aug. 31 -- Clinical trials are the foundation of drug development, providing the evidence needed to determine whether a treatment is effective and safe for patients. A single clinical trial rea... Read More

Ascendis, BioMarin Enter Global Settlement, License Deal For YUVIWEL; Ascendis Stock Up

India, Aug. 31 -- Ascendis Pharma A/S (ASND) announced on Monday that it has entered into a binding term sheet with BioMarin Pharmaceutical Inc. (BMRN) for a global settlement and license agreement co... Read More

• ««
• «
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »
• »»